| pubmed-article:16105052 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16105052 | lifeskim:mentions | umls-concept:C0262950 | lld:lifeskim |
| pubmed-article:16105052 | lifeskim:mentions | umls-concept:C0030520 | lld:lifeskim |
| pubmed-article:16105052 | lifeskim:mentions | umls-concept:C0035086 | lld:lifeskim |
| pubmed-article:16105052 | lifeskim:mentions | umls-concept:C0242485 | lld:lifeskim |
| pubmed-article:16105052 | lifeskim:mentions | umls-concept:C0205369 | lld:lifeskim |
| pubmed-article:16105052 | lifeskim:mentions | umls-concept:C0376315 | lld:lifeskim |
| pubmed-article:16105052 | lifeskim:mentions | umls-concept:C1516048 | lld:lifeskim |
| pubmed-article:16105052 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:16105052 | pubmed:dateCreated | 2005-8-17 | lld:pubmed |
| pubmed-article:16105052 | pubmed:abstractText | Parathyroid hormone (PTH) measurements serve as a noninvasive, diagnostic tool for the assessment of renal osteodystrophy (ROD). Their value has been questioned following reports indicating that all commercially available intact PTH (I-PTH) assays cross-react with amino terminally truncated PTH fragments. Because these fragments can account for 50% of total PTH, their detection will overestimate the true PTH concentration and may lead to diagnostic inaccuracies. The aim of this study was to evaluate the specific Bio-Intact PTH (1-84) Assay (BI-PTH) in patients with various types of ROD confirmed by bone biopsy. | lld:pubmed |
| pubmed-article:16105052 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16105052 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16105052 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16105052 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16105052 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16105052 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16105052 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16105052 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:16105052 | pubmed:issn | 0085-2538 | lld:pubmed |
| pubmed-article:16105052 | pubmed:author | pubmed-author:SteinGünterG | lld:pubmed |
| pubmed-article:16105052 | pubmed:author | pubmed-author:GoodmanWillia... | lld:pubmed |
| pubmed-article:16105052 | pubmed:author | pubmed-author:LehmannGabrie... | lld:pubmed |
| pubmed-article:16105052 | pubmed:author | pubmed-author:SchemerRudolf... | lld:pubmed |
| pubmed-article:16105052 | pubmed:author | pubmed-author:HüllerManfred... | lld:pubmed |
| pubmed-article:16105052 | pubmed:author | pubmed-author:RamakrishnanK... | lld:pubmed |
| pubmed-article:16105052 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16105052 | pubmed:volume | 68 | lld:pubmed |
| pubmed-article:16105052 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16105052 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16105052 | pubmed:pagination | 1206-14 | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:meshHeading | pubmed-meshheading:16105052... | lld:pubmed |
| pubmed-article:16105052 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16105052 | pubmed:articleTitle | Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. | lld:pubmed |
| pubmed-article:16105052 | pubmed:affiliation | Division of Rheumatology and Osteology, Department of Internal Medicine III, Friedrich-Schiller University of Jena, Jena, Germany. gabriele.lehmann@med.uni-jena.de | lld:pubmed |
| pubmed-article:16105052 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16105052 | lld:pubmed |
